7 hrs ago
Bristol-Myers Squibb: Great Dividend Stocks From The Bond Refugee...
BMY stock is expensive,on a relative basis, to the S&P 500 and healthcare sector earnings multiples and projected five year growth rates.
Trending on the Topix Network
Tue Apr 22, 2014
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement
Financial terms of the agreement are not disclosed. Bristol-Myers Squibb and Samsung announced their first manufacturing agreement in July 2013 to collaborate in the production of a single commercial antibody cancer drug substance.
Mon Apr 21, 2014
The Hartford Courant
Reader Submitted: International Sales Director Appointed
USA beauty distributor/exporter Beauty Enterprises Inc. has appointed Christopher Bueter as international sales director.
Tue Apr 15, 2014
BMS Files Reyataz-Cobicistat Combo Tablet NDA For HIV-1
Bristol-Myers Squibb announced the filing of a New Drug Application for the fixed-dose combination tablet of atazanavir sulfate with cobicistat for the treatment of patients with HIV-1.
The Motley Fool
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?
Does Merck stand a chance? Merck has lagged the hepatitis C race, but the phase 2 results from its oral combination of MK-5172 and MK-8742 in genotype 1 patients are quite impressive.
UPDATE 1-Boehringer 2013 profit up on Pradaxa sales, cost cuts
German drugmaker Boehringer Ingelheim's operating income rose 14 percent last year as cost cuts and sales of anti-blood-clotting drug Pradaxa helped counter the impact of currency effects, it said on Tuesday.
Sun Apr 13, 2014
Customer Interaction Solutions
Anti-Tumor Drugs Market - Global Industry Analysis, Size, Share,...
Albany, New York, USA April 13, 2014 Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues.
Sat Apr 12, 2014
Bristol-Myers Squibb, FCB Sue Omnicom, Schulman Over Trade Secrets
A nasty court fight is taking shape in New York between Interpublic's FCB and its client Bristol-Myers Squibb on one side and a former FCB account manager, Stephanie Shulman and Omnicom Group on the other.
Fri Apr 11, 2014
The Toronto Star
Denied experimental drug, cancer patient pins hope on new clinical trial
If that doesn't work, Adrienne Lotton may travel to the U.S. to try a similar drug released for compassionate use.
Tue Apr 08, 2014
HIV and Hepatitis
Bristol-Myers Squibb Requests FDA Approval of Daclatasvir and Asunaprevir
Bristol-Myers Squibb has submitted New Drug Applications asking the U.S. Food and Drug Administration to approve its experimental hepatitis C virus NS5A inhibitor daclatasvir and HCV protease inhibitor asunaprevir, the company announced this week.
Contract Pharma Breaking News
DKSH, BMS Extend Asia-Pac Partnership
DKSH , a market expansion services provider with a focus on Asia, has extended its partnership with Bristol-Myers Squibb to provide commercial and distribution services in Asia covering six markets: Hong Kong, Malaysia, Singapore, Taiwan, Thailand and Vietnam.
European Researchers Invited to Submit Study Proposals for...
Partnering for Cure is Bristol-Myers Squibb's flagship, Pan-European scientific initiative supporting breakthrough research and facilitating greater collaboration and knowledge-sharing with the virology community , Bristol-Myers Squibb invites European researchers to submit innovative research ideas that aim to cure chronic virological diseases.
Mon Apr 07, 2014
Bristol-Myers Squibb Submits NDAs for Daclatasvir and Asunaprevir to...
Bristol-Myers Squibb Company announced today that they have submitted new drug applications with the U.S. Food and Drug Administration for the investigational products daclatasvir , an NS5A replication complex inhibitor, and asunaprevir , a NS3 protease inhibitor.
Bristol-Myers submits NDAs for Hep C drugs
Bristol-Myers Squibb submits new drug applications to the FDA for its NS5A replication complex inhibitor daclatasvir and its NS3 protease inhibitor asunaprevir for the treatment of Hepatitis C. The European Medicines Agency and Japan's Pharmaceutical and Medical Devices Agency are also reviewing the products under accelerated processes.
Tue Apr 01, 2014
Bristol-Myers Squibb to Announce Results for First Quarter 2014 on April 29
Bristol-Myers Squibb Company will announce results for the first quarter of 2014 on Tuesday, April 29, 2014.
Thu Mar 27, 2014
A Look Back At Big Pharma Stocks
Four years ago, I wrote about what I called "Big Pharma's Lost Decade" in the stock market.
Paltrow's 'conscious uncoupling' after 10 years of 'conscious coupling'
Gwyneth Paltrow attends Hollywood Stands Up To Cancer Event with contributors American Cancer Society and Bristol Myers Squibb on 1/28/14.
The Motley Fool
Big Pharma's Not-So-Hidden Secret to Success
Organic pipeline innovation and acquisitions aside, this has been the biggest driver of Big Pharma's success in recent years.
Wed Mar 26, 2014
Gwyneth Paltrow and Chris Martin escaped to Bahamas before announcing ...
Singer/Songwriter Chris Martin and actress Gwyneth Paltrow attend Hollywood Stands Up To Cancer Event with contributors American Cancer Society and Bristol Myers Squibb hosted by Jim Toth and Reese Witherspoon The former couple confirmed they were ending their marriage of over ten years via a statement on Gwyneth's Goop website on Tuesday.